General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

Unawareness of Illness and Neuropsychological Performance in Chronic Schizophrenia.

 

Young DA; Davila R & Scher H.

Schizophrenia Research, 10:117-124, 1993

RELEVANCE FOR EARLY INTERVENTION

This study reports on data that implicates frontal lobe dysfunction in the etiology of poor insight in patients with chronic schizophrenia. Previous authors had hypothesized that frontal lobe pathology may account for the severe forms of unawareness frequently seen in certain psychotic disorders (see recommended review article: Amador et al., 1991). Young and his colleagues tested this hypothesis using neuropsychological tests and the Scale to assess Unawareness of Mental Disorder. The results indicated that poor performance on tests of frontal function predicted poor insight independent of other cognitive functions tested including IQ. These results lend important support to the idea that poor insight into illness and resulting treatment refusal stem from a mental defect rather than informed choice.

General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity   
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of all material available on the Center's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated.  All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made to the Treatment Advocacy Center.  Please feel free to call with questions on mental illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send questions via email to [email protected].    Write to us at:  The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite 220; Arlington, VA  22201.  Technical comments on the Center's website (www.psychlaws.org) can be sent to [email protected]. The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation.  Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170.